TrialmAbs
Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial.
Won Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
pooled ittrialcites it